You can find the annual or quarterly income statement of Regencell Bioscience Holdings Ltd here for insights into the performance and operational efficiency of Regencell Bioscience Holdings Ltd.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

Operating expenses

-14.74%2.42M

-32.59%2.31M

-28.16%2.84M

-6.27%3.43M

--3.96M

--3.66M

R&D expenses

151.23%581.48K

-64.10%484.75K

-83.43%231.46K

21.05%1.35M

--1.40M

--1.12M

Operating profit

14.74%-2.42M

32.59%-2.31M

28.16%-2.84M

6.27%-3.43M

---3.96M

---3.66M

Net non-operating interest income (expenses)

Other non-operating income (expenses)

155.03%247.54K

10.22%125.96K

319.71%97.06K

128303.37%114.28K

--23.13K

--89.00

Income before tax

20.74%-2.18M

34.07%-2.19M

30.20%-2.75M

9.39%-3.32M

---3.94M

---3.66M

Income tax

----

--0.00

Income after tax

20.74%-2.18M

34.07%-2.19M

30.20%-2.75M

9.39%-3.32M

---3.94M

---3.66M

Net income from continuous operations

20.74%-2.18M

34.07%-2.19M

30.20%-2.75M

9.39%-3.32M

---3.94M

---3.66M

Net Income attributable to non-controlling interests

156.02%57.89K

-35.75%-119.27K

-27.19%-103.34K

-30.43%-87.86K

---81.25K

---67.36K

Net income attributable to controlling interests

15.45%-2.24M

35.97%-2.07M

31.41%-2.64M

10.14%-3.23M

---3.85M

---3.59M

Net income attributable to common shareholders

15.45%-2.24M

35.97%-2.07M

31.41%-2.64M

10.14%-3.23M

---3.85M

---3.59M

Basic earnings per share

15.45%-0.17

35.97%-0.16

32.50%-0.20

13.06%-0.25

---0.30

---0.29

Diluted earnings per share

15.45%-0.17

35.97%-0.16

32.50%-0.20

13.06%-0.25

---0.30

---0.29

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

